Exceptional innovation and translational research strategies.
The business challenges for innovators are almost as complex as the science itself — having the right innovation strategy is mission critical. If you answer “no” to any of the following questions, contact me for a free consultation!
Are your business goals and strategic objectives clear enough to guide – rather than follow – your R&D program?
Are your innovation strategies aligned with the mission and vision for your enterprise? Even for-profits and not-for-profits often need custom solutions!
Does your innovation strategy reflect your institutional policies and encompass the staff and the expert networks you must deploy in order to develop and translate research results into products? If not, what’s missing?
Are your board, management and staff trained to maximize their effectiveness in developing and implementing your innovation strategy?
Are you entering into strategic collaborations according to a careful plan to leverage your technology capital and address strategic needs?
Are your IP strategy and IP portfolio credible to investors and strategic partners?
Does your strategy for market exclusivity guide your research from a very early stage, secure regulatory exclusivity in addition to patent rights, and maximize enterprise value?
Do you have a strategy for acquiring technology competencies? For monetizing and out-licensing assets that you don’t need?
Does your overall technology development strategy provide a clear competitive advantage in seeking and negotiating technology transactions?
Do you have cutting edge strategies and an expert team to manage your patent and technology transfer programs?
Are you thinking globally while being practical about managing strategic technology and IP costs?
To see whether you can meet these challenges more successfully, contact Reid Adler, founder and principal of Practical Innovation Strategy.
“I specialize in optimizing the translational potential of innovative research & development programs through a focused and strategic planning process.”
I’ve worked with Reid on technology transfer with the Department of Defense and also on corporate IP strategies, and was highly impressed with his strategic thinking and negotiating style. He was able to significantly expedite a licensing transaction and he understood our business objectives completely. Reid has also helped to design our patent claim strategy.
Shawn K. Singh, Chief Executive Officer, VistaGen Therapeutics, Inc.